id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-2660-0009,FDA,FDA-2015-E-2660,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2018-05-11T04:00:00Z,2018,5,2018-05-11T04:00:00Z,,2018-05-11T15:23:34Z,,0,0,090000648325a6af
FDA-2015-E-2660-0008,FDA,FDA-2015-E-2660,"Determination of Regulatory Review Period for Purposes of Patent
Extension; OBIZUR",Notice,Determinations,2017-10-23T04:00:00Z,2017,10,2017-10-23T04:00:00Z,2017-12-23T04:59:59Z,2017-10-23T14:24:13Z,2017-22898,0,0,0900006482bf7dcc
FDA-2015-E-2660-0007,FDA,FDA-2015-E-2660,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2017-07-07T04:00:00Z,2017,7,2017-07-07T04:00:00Z,,2017-07-07T21:19:00Z,,0,0,09000064828463dc
FDA-2015-E-2660-0006,FDA,FDA-2015-E-2660,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T17:15:43Z,,0,0,0900006482434443
FDA-2015-E-2660-0005,FDA,FDA-2015-E-2660,Correction of Eligibility Letter for OBIZUR from FDA CDER to Lathrop and Gage LLP,Other,Letter(s),2016-01-11T05:00:00Z,2016,1,2016-01-11T05:00:00Z,,2016-01-11T19:07:24Z,,0,0,0900006481dfe2f2
FDA-2015-E-2660-0004,FDA,FDA-2015-E-2660,Correction of Eligibility Letter for OBIZUR from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-01-11T05:00:00Z,2016,1,2016-01-11T05:00:00Z,,2016-01-11T19:07:12Z,,0,0,0900006481dfe2ef
FDA-2015-E-2660-0003,FDA,FDA-2015-E-2660,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T15:50:59Z,,0,0,0900006481cd573a
FDA-2015-E-2660-0002,FDA,FDA-2015-E-2660,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T12:14:46Z,,0,0,0900006481ba5783
FDA-2015-E-2660-0001,FDA,FDA-2015-E-2660,"Patent Extension Application from Lathrop & Gage LLP (on behalf of  Emory University, Baxter International Inc., and Baxter Healthcare SA)",Other,Application,2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T12:14:32Z,,0,0,0900006481ba5785